These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 12045431)
21. [Parascapular lipoma with expression of somatostatin receptors detected by (99m)Tc-EDDA/HYNIC-TOC scintigraphy]. Mendoza Narváez JA; Bellón Guardia ME; García Vicente AM; Palomar Muñoz A; Talavera Rubio MP; Soriano Castrejón AM Rev Esp Med Nucl Imagen Mol; 2012; 31(4):225-6. PubMed ID: 23067692 [No Abstract] [Full Text] [Related]
22. Multiple bone metastases of hepatocellular carcinoma. Kubota T Ann Nucl Med; 2001 Dec; 15(6):front cover, 520. PubMed ID: 11831405 [No Abstract] [Full Text] [Related]
23. Detection of late chest wall recurrence of breast carcinoma during Tc-99m sestamibi parathyroid scintigraphy. Conrad GR; Sloan DA; Sinha P Clin Nucl Med; 2003 May; 28(5):408-9. PubMed ID: 12702942 [No Abstract] [Full Text] [Related]
24. Tc-99m depreotide SPECT demonstrates photon-deficiency in the thoracic vertebrae after adjunct radiation therapy of lung cancer: correlation with MRI and bone scintigraphy. Shih WJ; Van Wyk C Ann Nucl Med; 2003 May; 17(3):245-8. PubMed ID: 12846548 [TBL] [Abstract][Full Text] [Related]
25. Discrepant uptake between 111In-pentetreotide and 99mTc-MDP in bone metastases of small-cell lung cancer. Meristoudis G; Ilias I; Giannakopoulos V; Batsakis C; Christakopoulou J Hell J Nucl Med; 2009; 12(3):283-4. PubMed ID: 19936347 [No Abstract] [Full Text] [Related]
26. Bone metastases demonstrated by pentavalent Tc-99m DMSA and Tc-99m HMDP. Hirano T; Otake H Clin Nucl Med; 1997 Sep; 22(9):640-1. PubMed ID: 9298304 [No Abstract] [Full Text] [Related]
27. Contribution of (99m)Tc-depreotide (Neospect) scintigraphy in lung cancer staging. Karathanos E; Datseris I; Vlontzou E; Zisimopoulos A; Georgiou E J BUON; 2010; 15(1):147-52. PubMed ID: 20414943 [TBL] [Abstract][Full Text] [Related]
28. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA. Yen TC; King KL; Yang AH; Liu RS; Yeh SH J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007 [TBL] [Abstract][Full Text] [Related]
29. Quantitative assessment of 99mTc-depreotide uptake in patients with non-small-cell lung cancer: immunohistochemical correlations. Herlin G; Kölbeck KG; Menzel PL; Svensson L; Aspelin P; Capitanio A; Axelsson R Acta Radiol; 2009 Oct; 50(8):902-8. PubMed ID: 19707908 [TBL] [Abstract][Full Text] [Related]
30. A Clear Cell Variant of Papillary Thyroid Microcarcinoma With Lung, Bone, and Soft Tissue Metastases. Yazici B; Ertan Y; Oral A; Akgün A Clin Nucl Med; 2015 Nov; 40(11):885-7. PubMed ID: 26018685 [TBL] [Abstract][Full Text] [Related]
31. Tc-99m MDP bone scintigraphy in a patient with multicentric osteosarcoma. Cermik TF; Salan A; Firat MF; Berkarda S Clin Nucl Med; 2003 Jul; 28(7):599-600. PubMed ID: 12819421 [No Abstract] [Full Text] [Related]
32. Accumulation of Tc-99m depreotide (NeoSpect) in axillary sweat glands. Danielsson R; Bååth M; Kölbeck KG; Klominek J; Svensson L Clin Nucl Med; 2003 Sep; 28(9):789-90. PubMed ID: 12973013 [TBL] [Abstract][Full Text] [Related]
33. A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules. Blum J; Handmaker H; Lister-James J; Rinne N Chest; 2000 May; 117(5):1232-8. PubMed ID: 10807805 [TBL] [Abstract][Full Text] [Related]
34. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma. Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148 [TBL] [Abstract][Full Text] [Related]
35. The utility of two somatostatin analog radiopharmaceuticals in assessment of radiologically indeterminate pulmonary lesions. Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Saranovic DZ; Jaksic ED; Subotic D; Nagorni-Obradovic L; Kozarevic N; Petrovic N; Grozdic IT; Obradovic VB Clin Nucl Med; 2012 Jan; 37(1):14-20. PubMed ID: 22157022 [TBL] [Abstract][Full Text] [Related]
36. Utility of Tc-99m GSA whole-body scintigraphy in detecting bone metastases from hepatocellular carcinoma. Sueyoshi K; Narabayashi I; Aratani T; Doi K; Komori T; Ogura Y; Utsunomiya K; Shimidzu T Clin Nucl Med; 2001 Mar; 26(3):221-4. PubMed ID: 11245114 [TBL] [Abstract][Full Text] [Related]
37. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma. Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065 [TBL] [Abstract][Full Text] [Related]
38. The effect of bevacizumab for bone scintigraphy imaging: A case report. Asano T; Takakuwa O; Maeno K; Oguri T; Niimi A J Cancer Res Ther; 2015; 11(3):652. PubMed ID: 26458633 [TBL] [Abstract][Full Text] [Related]
39. An unusual case of a tibial metastasis as the clinical presentation of bronchogenic adenocarcinoma. Shih WJ; Magoun S; Lahar B; Stipp V; Gross K J Nucl Med Technol; 1998 Jun; 26(2):91-3. PubMed ID: 9604829 [TBL] [Abstract][Full Text] [Related]
40. Metatarsal metastasis from lung cancer read as a benign process on Tc-99m MDP scintigraphy. Duarte PS Clin Nucl Med; 2007 Jun; 32(6):501-3. PubMed ID: 17515771 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]